Medicare Part D drug Data year 2024 Generic name Source: CMS Part D Prescribers

Levothyroxine Sodium

Open in the dashboard

Part D claims

42,465,073

Prescriptions dispensed, refills included

Drug cost

$456,346,665

Paid at the pharmacy, in all

Prescribers

284,341

With 11 or more claims of it

In 2024, Medicare Part D recorded 42,465,073 claims for Levothyroxine Sodium from 284,341 prescribers, at a total drug cost of $456.3 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 59 states and territories

Part D claims for Levothyroxine Sodium by the state of the prescriber, 2024
State	Prescribers	Claims	Drug cost
CA	28,785	3,596,994	$47,823,528
FL	19,564	3,102,675	$32,165,626
TX	20,132	3,017,918	$30,321,507
NY	17,403	2,322,357	$30,531,010
PA	12,332	2,153,099	$23,632,157
OH	10,429	1,805,504	$17,328,784
IL	9,774	1,526,663	$15,975,903
MI	9,793	1,503,741	$19,030,881
NC	9,474	1,380,610	$13,609,510
GA	7,364	1,207,517	$11,464,112
TN	6,406	1,099,293	$9,337,238
IN	5,994	1,068,421	$9,784,917
MO	5,360	1,038,885	$9,207,622
NJ	6,951	992,201	$11,136,649
AZ	6,140	926,539	$9,121,696

The other 44 states and territories

State	Prescribers	Claims	Drug cost
MA	7,182	882,018	$9,215,267
VA	6,532	869,039	$9,056,942
KY	4,539	831,757	$8,193,696
WA	7,159	827,759	$9,255,225
WI	5,357	818,443	$8,799,941
MN	5,547	749,163	$9,909,631
AL	3,968	709,418	$8,640,634
CO	5,305	697,634	$7,662,713
SC	4,568	694,447	$7,136,813
LA	3,995	646,250	$5,582,301
IA	3,119	587,094	$4,888,118
OR	4,407	571,054	$6,980,457
PR	2,903	532,641	$6,363,034
MD	4,675	516,475	$6,026,953
OK	3,116	512,175	$4,952,988
KS	2,778	506,750	$4,293,107
AR	2,960	497,576	$4,339,030
CT	3,256	476,400	$5,098,154
WV	1,999	357,088	$3,818,326
MS	2,639	352,909	$2,851,601
NE	1,981	352,314	$3,137,845
UT	2,293	316,638	$3,546,534
NV	2,324	313,418	$3,259,722
NM	1,932	291,183	$3,476,497
ID	1,978	283,121	$2,896,377
ME	1,798	237,075	$2,562,026
NH	1,551	190,895	$1,933,406
MT	1,213	184,023	$1,807,113
SD	953	159,093	$1,512,017
RI	1,081	152,954	$1,783,517
ND	884	132,855	$1,669,404
DE	904	123,407	$1,396,605
HI	987	94,917	$874,950
WY	564	84,514	$806,762
VT	717	81,814	$1,046,435
AK	548	40,402	$483,279
DC	600	37,467	$467,750
VI	47	3,535	$61,728
GU	34	2,838	$36,504
ZZ	15	1,212	$18,556
XX	7	1,106	$10,622
AP	11	896	$10,654
AE	10	730	$10,313
MP	4	159	$1,979

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 120

Part D claims for Levothyroxine Sodium by prescriber specialty, 2024
Specialty	Prescribers	Claims	Drug cost
Family Practice	80,690	14,869,101	$157,619,191
Internal Medicine	58,950	12,617,466	$140,898,818
Nurse Practitioner	79,480	7,656,995	$77,458,317
Physician Assistant	25,046	2,526,008	$26,594,081
Endocrinology	6,223	2,140,990	$25,675,827
General Practice	4,350	755,059	$7,971,378
Geriatric Medicine	1,503	371,801	$4,179,537
Cardiology	3,375	200,565	$2,328,900
Hospitalist	2,107	182,725	$1,988,823
Emergency Medicine	1,099	152,577	$1,528,683
Hematology-Oncology	3,137	111,342	$960,177
Nephrology	1,710	89,290	$971,414
Pediatric Medicine	654	70,774	$753,060
Student in an Organized Health Care Education/Training Program	3,133	64,196	$659,707
Otolaryngology	1,245	58,822	$560,344

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber	Specialty	State	Claims	Drug cost	Related payments
Robert Pearlstein	Internal Medicine	PA	13,398	$128,669	None on record
Donald Vollmer	Family Practice	TN	8,004	$56,039	None on record
Wyatt Blake	Emergency Medicine	GA	7,088	$45,050	None on record
Brandon Roscoe	Family Practice	PA	6,286	$75,068	None on record
Leon Butler	Internal Medicine	KY	5,367	$59,060	None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Levothyroxine Sodium

$1,000 in general payments reported against it, with the companies and doctors behind them.

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for levothyroxine sodium

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.